Lakefront Biotherapeutics | GLPG - 应收帐款人





应收帐款人 更改 日
argenx SE USD 1.66B 458.83M 2025-12
AstraZeneca USD 17.88B 1.17B 2026-03
Biogen USD 1.79B 76.6M 2026-03
Genmab DKK 1.17B 119M 2025-12
Gilead Sciences USD 4.74B 172M 2026-03
GlaxoSmithKline GBP 7.94B 178M 2026-03
GRIFOLS EUR 958M 106M 2026-03
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Incyte USD 1.05B 27.09M 2026-03
Merck EUR 4.81B 373M 2026-03
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Novartis USD 9.6B 2.69B 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sanofi EUR 482M 85M 2026-03
UCB EUR 1.97B 54M 2025-12
Vertex Pharmaceuticals USD 2B 56.7M 2026-03